Doxazosin Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 12 USDMF, 9 CEP/COS, 7 JDMF, 7 EU WC, 6 KDMF, 8 NDC API, 20 Listed Suppliers, $ API Reference Price

INTERMEDIATES

17 Intermediates Suppliers

17 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 82 FDA Orange Book, 219 Europe, 12 Canada, 9 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 1MG BASE, TABLET;ORAL - EQ 2MG BASE, TABLET;ORAL - EQ 4MG BASE, TABLET;ORAL - EQ 8MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 8MG BASE

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 4 DKSH, 5 Faran Shimi Pharmaceutical, 12 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 15 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 31 Direct Compression, 28 Disintegrants & Superdisintegrants, 25 Controlled & Modified Release, 21 Granulation, 18 Thickeners and Stabilizers, 15 Co-Processed Excipients, 14 Lubricants & Glidants, 9 Taste Masking, 8 Topical, 7 Film Formers & Plasticizers, 6 Chewable & Orodispersible Aids, 5 Coloring Agents, 5 Solubilizers, 5 Parenteral, 5 Empty Capsules, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Rheology Modifiers, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 11 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 200 Finished Drug Prices, 3 Annual Reports

MARKET PLACE

7 APIs, 2 FDF Dossiers, 1 Intermediates

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 4 JP, 9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 21269 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - EQ 4MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
DOXAZOSIN MESYLATE(UNII: 86P6PQK0MU) (DOXAZOSIN - UNII:NW1291F1W8)	DOXAZOSIN	8mg \| 8mg \| 4mg \| 4mg

Inactive Ingredients

Ingredient Name	Roerig
CELLULOSE ACETATE(3J2P07GVB6)
FERRIC OXIDE RED(1K09F3G675)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
SODIUM CHLORIDE(451W47IQ8X)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Doxazosin Mesylate